Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
Preeti Singh (talk | contribs) No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
| Line 17: | Line 17: | ||
| rowspan="10" |'''Infections''' | | rowspan="10" |'''Infections''' | ||
| rowspan="4" |'''Bacterial''' | | rowspan="4" |'''Bacterial''' | ||
| rowspan="2" |Syphilis | | rowspan="2" |'''Syphilis''' | ||
| | | | ||
| | | | ||
| Line 34: | Line 34: | ||
| | | | ||
|- | |- | ||
| rowspan="2" |Brucellosis | | rowspan="2" |'''Brucellosis''' | ||
| | | | ||
| | | | ||
| Line 52: | Line 52: | ||
|- | |- | ||
| rowspan="4" |'''Viral''' | | rowspan="4" |'''Viral''' | ||
|infectious mononucleosis | |'''infectious mononucleosis''' | ||
| | | | ||
| | | | ||
| Line 61: | Line 61: | ||
| | | | ||
|- | |- | ||
|cytomegalovirus | |'''cytomegalovirus''' | ||
| | | | ||
| | | | ||
| Line 70: | Line 70: | ||
| | | | ||
|- | |- | ||
|human immunodeficiency virus | |'''human immunodeficiency virus''' | ||
| | | | ||
| | | | ||
| Line 79: | Line 79: | ||
| | | | ||
|- | |- | ||
|cat scratch fever | |'''cat scratch fever''' | ||
| | | | ||
| | | | ||
| Line 89: | Line 89: | ||
|- | |- | ||
|'''Mycobacterial''' | |'''Mycobacterial''' | ||
|tuberculosis | |'''tuberculosis''' | ||
| | | | ||
| | | | ||
| Line 99: | Line 99: | ||
|- | |- | ||
|'''Parasitic''' | |'''Parasitic''' | ||
|toxoplasmosis | |'''toxoplasmosis''' | ||
| | | | ||
| | | | ||
| Line 109: | Line 109: | ||
|- | |- | ||
| rowspan="4" |'''Autoimmune''' | | rowspan="4" |'''Autoimmune''' | ||
|'''Systemic lupus erythematosus''' | | colspan="2" |'''Systemic lupus erythematosus''' | ||
| | | | ||
| | | | ||
| Line 119: | Line 118: | ||
| | | | ||
|- | |- | ||
|'''Sjögren's syndrome''' | | colspan="2" |'''Sjögren's syndrome''' | ||
| | | | ||
| | | | ||
| Line 129: | Line 127: | ||
| | | | ||
|- | |- | ||
|'''Hydantoin derivatives''' | | colspan="2" |'''Hydantoin derivatives''' | ||
| | | | ||
| | | | ||
| Line 139: | Line 136: | ||
| | | | ||
|- | |- | ||
|'''Sarcoidosis''' | | colspan="2" |'''Sarcoidosis''' | ||
| | | | ||
| | | | ||
| Line 150: | Line 146: | ||
|- | |- | ||
| rowspan="6" |'''Neoplasms''' | | rowspan="6" |'''Neoplasms''' | ||
| colspan=" | | colspan="2" rowspan="1" |'''Hodgkin's disease''' | ||
| | | | ||
| | | | ||
| Line 160: | Line 155: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Chronic lymphocytic leukemia''' | ||
| | | | ||
| | | | ||
| Line 170: | Line 164: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Small cell carcinoma of the lung''' | ||
| | | | ||
| | | | ||
| Line 180: | Line 173: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Malignant histiocytosis''' | ||
| | | | ||
| | | | ||
| Line 190: | Line 182: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Melanoma''' | ||
| | | | ||
| | | | ||
| Line 200: | Line 191: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Germ cell neoplasms''' | ||
| | | | ||
| | | | ||
| Line 211: | Line 201: | ||
|- | |- | ||
| rowspan="5" |'''Other conditions''' | | rowspan="5" |'''Other conditions''' | ||
| colspan=" | | colspan="2" rowspan="1" |'''Reactive lymphoid hyperplasia''' | ||
| | | | ||
| | | | ||
| Line 221: | Line 210: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Lymphomatoid granulomatosis''' | ||
| | | | ||
| | | | ||
| Line 231: | Line 219: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Dermatopathic lymphadenopathy''' | ||
| | | | ||
| | | | ||
| Line 241: | Line 228: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Angioimmunoblastic lymphadenopathy''' | ||
| | | | ||
| | | | ||
| Line 251: | Line 237: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="2" rowspan="1" |'''Giant lymph node hyperplasia (Castleman disease)''' | ||
| | | | ||
| | | | ||
Revision as of 15:34, 19 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
| Pathophysiology | Symptoms | History | Physical Examination | Laboratory Findings | |||||
|---|---|---|---|---|---|---|---|---|---|
| Immunochemistry | Blood work | Biospy | |||||||
| Infections | Bacterial | Syphilis | |||||||
| Brucellosis | |||||||||
| Viral | infectious mononucleosis | ||||||||
| cytomegalovirus | |||||||||
| human immunodeficiency virus | |||||||||
| cat scratch fever | |||||||||
| Mycobacterial | tuberculosis | ||||||||
| Parasitic | toxoplasmosis | ||||||||
| Autoimmune | Systemic lupus erythematosus | ||||||||
| Sjögren's syndrome | |||||||||
| Hydantoin derivatives | |||||||||
| Sarcoidosis | |||||||||
| Neoplasms | Hodgkin's disease | ||||||||
| Chronic lymphocytic leukemia | |||||||||
| Small cell carcinoma of the lung | |||||||||
| Malignant histiocytosis | |||||||||
| Melanoma | |||||||||
| Germ cell neoplasms | |||||||||
| Other conditions | Reactive lymphoid hyperplasia | ||||||||
| Lymphomatoid granulomatosis | |||||||||
| Dermatopathic lymphadenopathy | |||||||||
| Angioimmunoblastic lymphadenopathy | |||||||||
| Giant lymph node hyperplasia (Castleman disease) | |||||||||